
Istituto Biochimico Italiano (IBI)
Istituto Biochimico Italiano (Ibi) founded by Prof. Giovanni Lorenzini, is a pharmaceutical company of great scientific tradition in the Italian market from more than 90 years, with research objectives, innovation and production. Besides the historical firm tradition, the new technologies applied in the production and careful attention, make Ibi synonymous with reliability and quality assurance in the countries where the Company is present.
Ibi is dedicating its activity to the development of new therapeutic applications to offer alternative solutions to doctors and patients and is now well established in Italy, Europe, Asia, Australia and the US.
With its 45mio vials capacity of filling in asepsis, Ibi offers services and cutting-edge technology which put it among the top 10 Italian companies in contract manufacturing of different molecules. Ibi exports most of its products, equivalent to 2/3 of the production and is one of the few companies outside American territory, to have obtained FDA approval for the production of sterile penicillins for the US market.



